Trade Summary

2 days ago, Van Tuyl Christopher, serving as Chief Legal Officer at Immunovant, Inc. (IMVT), sold 17,824 shares at $38.31 per share, for a total transaction value of $682,886.90. Following this transaction, Van Tuyl Christopher now holds 180,597 shares of IMVT.

This sale represents a 8.98% decrease in Van Tuyl Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 7:45 PM ET, meaning the disclosure happened on the same day as the trade.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.